Supplementary Material Abbreviations ACN acetonitrile aCSF artificial cerebrospinal fluid AngIV angiotensin IV ANOVA analysis of variance AUC area under the curve BBB blood-brain barrier Cl int average intrinsic clearance C max concentration in plasma extrapolated to time zero (C 0 ) dihexa N -hexanoic-Tyr-Ile-(6) amino-hexanoic amide DMSO dimethyl sulfoxide HGF hepatocyte growth factor HPLC high-pressure liquid chromatography logP log transformation of the octanol/water partition ratio and measure of hydrophilicity mEPSC miniature excitatory postsynaptic currents Nle 1 -AngIV Nle-Tyr-Ile-His-Pro-Phe PBS phosphate-buffered saline P eff predicted effective human jejunal permeability PIPES piperazine- N , N -bis(2-ethanesulfonic acid) t 1/2 terminal elimination rate constant V d volume of distribution VGLUT1 vesicular glutamate transporter 1 Authorship Contributions Participated in research design: McCoy, Benoist, Wright, Harding, Appleyard, Wayman, Kawas
For centuries, it was forgotten
This guide explores the current state of clinical trials in the US, key trends for 2026, and how patients and researchers can navigate this evolving ecosystem
Thinning hair or alopecia clients seeking a credible, non-hormonal hair restoration option
"Last IV bar felt like a spa, not a clinic." Doctor-assessed, nurse-administered every single drip